Series date: 
07/01/2020 - 7:00am CDT to 06/30/2021 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  

Frequency

Monthly

Series Director

Frank Y. Lin, MD

Target Audience and Needs

Pediatric oncologists, geneticists, molecular and anatomic pathologists, surgeons, genetic counselors, medical trainees, and other healthcare professionals involved in the care of pediatric patients with cancer need to be regularly updated with the recent advances and guidelines in the field of pediatric oncology. The tumor board aims to increase knowledge of the learners using a multidisciplinary case approach, and encourages learners to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Educational Methods

Educational methods will include case presentations and panel discussion.

Objectives

At the conclusion of the sessions, the participants should be able to:

  • Apply the results of tumor and germline molecular testing to the diagnosis, prognosis, and treatment of pediatric cancer.
  • Demonstrate the expanding role of molecular diagnostics in formulating pediatric precision-oncology treatment strategies.
  • Use a multidisciplinary approach in interpreting results of molecular diagnostics.
  • Appraise the molecular tests currently available in pediatric oncology and recognize the limitations and risks of using them.
Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 

MacKenzie Harris
mdharris@texaschildrens.org
832-824-4539

Series location: 
Texas Children's Hospital
6621 Fannin Street
Houston, TX 77030
United States
See map: Google Maps

Sessions

Session Date
An Adolescent with a Germline MSH6 Pathogenic Variant/An Adolescent with Relapsed Wilms Tumor and Intragenic EGFR Deletions 08/12/2020 - 12:00pm to 1:00pm CDT
QA Presentations: Genomic Alterations in Pediatric Juvenile Myelomonocytic Leukemia: A Study of Two Cases 10/14/2020 - 12:00pm to 1:00pm CDT
QA Presentations: Retroperitoneal Tumor with NTRK1 Fusion in a Toddler/Pleuropulmonary Blastoma with a DICER1 Mutation in a Toddler 11/11/2020 - 12:00pm to 1:00pm CST
QA Presentations: A Teenager with a High-Grade Optic Pathway Tumor with a High Tumor Mutation Burden/A School-Age Child with High-Grade Glioma with a High Tumor Mutation Burden 12/09/2020 - 12:00pm to 1:00pm CST
QA Presentations: Acute Myeloid Leukemia with a Germline CEBPA Variant 01/13/2021 - 12:00pm to 1:00pm CST
QA Presentations: An Adolescent/Young Adult with a History of Schwannoma and Acute Lymphocytic Leukemia with Germline Chromosome 22q11.23 Structural Variation Involving SMARCB1/An Adolescent with Metastatic Refractory Papillary Thyroid Carcinoma with NCOA 02/10/2021 - 12:00pm to 1:00pm CST
QA Presentations: An Adolescent Who Has Pilocytic Astrocytoma with a BRAF p.T599dup Mutation/A Preschool-Aged Child Who Has Diffuse Midline Glioma with an HIST1H3B (K27M) Mutation 03/10/2021 - 12:00pm to 1:00pm CST
QA Presentations: School-Aged Child with AML, Somatic JAK3 and NF1 Mutations, and Germline Intragenic RUNX1 Deletion / Adolescent/Young Adult with Adenocarcinoma of the Jejunum and a Germline APC Frameshift Variant 05/12/2021 - 12:00pm to 1:00pm CDT